Dermapharm Holding SE buy DirectorDealer
Start price
07.01.26
/
50%
€38.50
Target price
07.01.27
-
Performance (%)
18.70%
Price
13:41
€45.70
Summary
This prediction is currently active. The BUY prediction by DirectorDealer currently has a performance of 18.70%. This prediction currently runs until 07.01.27. The prediction end date can be changed by DirectorDealer at any time. DirectorDealer has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Dermapharm Holding SE | 9.211% | 9.211% |
| iShares Core DAX® | 0,44 % | 3,03 % |
| iShares Nasdaq 100 | 3,82 % | 4,07 % |
| iShares Nikkei 225® | 1,15 % | 6,90 % |
| iShares S&P 500 | 2,37 % | 2,68 % |
Comments by DirectorDealer for this prediction
In the thread Dermapharm Holding SE diskutieren
Director's Dealing / Insider Kauf von Dreibholz, Christof (Vorstand)
- Handelstag: 05.01.2026
- Volumen: 95825 €
- Meldende_r: Dreibholz, Christof